Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 40 (1), 16-22

An Open-Label, Prospective, Multicenter, Clinical Study to Evaluate Efficacy of Ayuartis Capsules in Patients Suffering From Osteoarthritis of the Knee(s)

Affiliations

An Open-Label, Prospective, Multicenter, Clinical Study to Evaluate Efficacy of Ayuartis Capsules in Patients Suffering From Osteoarthritis of the Knee(s)

Narendra B Mundhe et al. Ayu.

Abstract

Background: The management of chronic degenerative joint disorders such as osteoarthritis (OA) with ayurvedic medicines provides a safe and effective alternative. Ayurvedic medicines possess analgesic, anti-inflammatory, anti-oxidant and immunomodulator activities.

Aims: The main aim of the study was to assess the efficacy of Ayuartis capsule in patients suffering from OA of the knee(s).

Materials and methods: Thirty-one patients suffering from OA knee(s) were recruited after evaluating them as per inclusion/exclusion criteria. Patients were advised to take two Ayuartis capsules twice daily orally for 90 days. Knee joint(s) pain was assessed on the Visual Analog Scale. Patients' joint pain, stiffness, and physical functions were assessed on the Western Ontario McMaster University Osteoarthritis (WOMAC) index. Quality of life (QOL) and the time required to walk 50 feet was evaluated. Patients were called for follow-up visits on every 15th day till 90 days. Adverse events and vitals were recorded at every visit. Safety laboratory investigations were done before and after the completion of trial.

Statistical analysis: Data describing quantitative measures are expressed as mean ± standard deviation. The comparison of variables representing categorical data was performed using pair t-test.

Results: The mean joint pain reduced significantly by 53.82% on day 90. The mean WOMAC combined score, pain score, stiffness score and difficulty score reduced significantly by 50.88%, 54.96%, 58.76% and 49.02%, respectively on day 90. A significant improvement was observed in mean QOL of patients. A significant reduction in mean time required to walk 50 feet was observed. Majority of the patients had shown good overall improvement and excellent tolerability to the trial drug.

Conclusion: Ayuartis capsule is a safe and effective medicine for the treatment of OA of the knee(s).

Keywords: Ayuartis capsules; Visual Analog Scale; Western Ontario McMaster University Osteoarthritis; osteoarthritis; quality of life.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Effect of Ayuartis capsule on knee joint pain assessed on the Visual Analog Scale
Figure 2
Figure 2
Effect of Ayuartis capsule on the Western Ontario McMaster University Osteoarthritis index (combined score)
Figure 3
Figure 3
Effect of Ayuartis capsule on the Western Ontario McMaster University Osteoarthritis index (pain score)
Figure 4
Figure 4
Effect of Ayuartis capsule on the Western Ontario McMaster University Osteoarthritis index (stiffness score)
Figure 5
Figure 5
Effect of Ayuartis capsule on the Western Ontario McMaster University Osteoarthritis index (difficulty score)
Figure 6
Figure 6
Assessment of quality of life on Karnofsky and Lansky performance scale
Figure 7
Figure 7
Assessment of time to walk 50 feet on even surface

Similar articles

See all similar articles

References

    1. Mahajan A, Verma S, Tandon V. Osteoarthritis. J Assoc Physicians India. 2005;53:634–41. - PubMed
    1. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis. Arthritis Rheum. 1995;38:1535–40. - PubMed
    1. Alcaraz MJ, Megías J, García-Arnandis I, Clérigues V, Guillén MI. New molecular targets for the treatment of osteoarthritis. Biochem Pharmacol. 2010;80:13–21. - PubMed
    1. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: New insights. Part 1: The disease and its risk factors. Ann Intern Med. 2000;133:635–46. - PubMed
    1. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26:355–69. - PMC - PubMed
Feedback